All Access Articles |
- Arbutus Biopharma Reveals 2025 Objectives & Financial Update | 2025-01-13 | PHARMACEUTICAL
- Arbutus Biopharma Achieves 50% Functional Cure in Hepatitis B Trial | 2024-11-15 | PHARMACEUTICAL
- Arbutus Biopharma Q3 2024 Financial Results – $130.8M Cash, $1.3M Revenue, $63-67M Cash Burn Est. | 2024-11-06 | PHARMACEUTICAL